# A Safety, Tolerability, PD and PK Study in Healthy Adults

> **NCT02211625** · PHASE1 · COMPLETED · sponsor: **Trevena Inc.** · enrollment: 75 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Open-label TRV734 125 mg
- **DRUG:** TRV734 blinded
- **DRUG:** Oxycodone IR 10 mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02211625
- **Lead sponsor:** Trevena Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2014-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02211625

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02211625, "A Safety, Tolerability, PD and PK Study in Healthy Adults". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02211625. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*